Paul Thomen

Thursday, 18 April 2013

Cord Blood Banking Industry Opportunities Growth 2013

This report is available at a flat 25% Discount on all license types till April 30, 2013. Listed above are original prices and the discount is applicable on the same.

The cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as within most developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry, over only a seven year period. This rapid market growth represents both an opportunity to profit, as well as swarming competition.

BioInformant’s recently launched industry report "Capitalizing on Opportunities in Cord Blood Industry Growth" addresses this issue by strategically positioning cord blood banks to expand, profit, and outmaneuver the competition.

The report also reveals strategies for dominating the global cord blood banking industry, including tactics for global expansion, patterns in regional dominance, and methods for investing in the sector. A distinctive feature is a global survey of expectant parents who reveal their deepest fears, core expectations, and critical factors influencing buying decisions. It is designed to guide the decision-making of cord blood banks worldwide, as well as to advise private, corporate, and institutional investors entering into the global cord blood banking market.

It differs from "The Complete U.S. 2012-13 Cord Blood Banking Industry Report," in that it is a strategic overview of how to profit from the global cord blood banking market, rather than from the U.S. markets alone.

The first part of the industry report, titled “Global Cord Blood Banking Industry - Market Overview & Outlook,” lays a foundation for industry competence by exploring where the cord blood banking industry has been, what has shaped it, and where it is going.  With this detailed knowledge, cord blood banks can quicky identify their relative strength within the marketplace.

The second part of the report, titled “Expansion and Growth – Trailing 12-Month Analysis & Forward Projections,” reveals trends within the global cord blood banking industry and what cord blood banks should anticipate for the near-term future. This section explores trends across a large variety of industry metrics and provides forward five-year projections. Critically, it also explores strategies of fast-growth companies and compares their attributes to slow-growth companies, providing a comprehensive road-map to industry dominance. To guide industry competitors, this section considers the following questions:
·         What factors are causing a substantial number of new cord blood banks to open up business?
·         What will be the effect of these new entrants to the cord blood banking industry?
·         How can existing competitors maintain a position of dominance among this trend?

The third and final part of the report, titled “Comprehensive Parent Survey - Continuing to Grow by Listening to Expectant Parents,” contains survey results from more than 200 parents worldwide.  Key findings from this survey include how to:
·         Strategically position cord blood and cord tissue services
·         Understand why expectant parents bank publicly, privately, or not at all
·         Communicate successfully with parents
·         Effectively educate parents
·         Prioritize an advertising budget
·         Sell more effectively

A Fast-Growth Industry, Driven by Medical Necessity and Consumer Demand

The field of cord blood banking is a fast-growth field, driven by medical necessity and consumer demand. It is a recent industry, as it was not until 1974 that it was first proposed that stem and progenitor cells were present in human cord blood and 1983 that umbilical cord blood was proposed as an alternative source of stem cells for transplant. In 1988, the first successful cord blood transplant occurred, but it was not until 1995 that the first private cord blood bank began operations.

Furthermore, it was not until 2009 that a Taiwanese company, HealthBanks Biotech Company, Ltd., begane the first private cord blood bank to offer umbilical cord tissue storage. HealthBaby, a Hong Kong based company subsequently launched the service in 2009, and another Hong Kong based company, Cryolife, also added the service in 2009. As such, Asia is recognized as the geographic region that pioneered umbilical cord tissue preservation as a private service, but it has since has rapidly spread around the world.

For instance, nine U.S. cord blood banks now offer cord tissue storage. While the first U.S. company to offer cord tissue storage was the Cord Blood Registry, who launched it in July of 2010, the number of U.S. cord blood banks offering cord tissue storage has since risen to nine. This represents an average of one new U.S. cord blood bank adding cord tissue storage every 3-4 months. Similar trends have been observed within Europe, to a slightly lesser extent, the Middle East.

Table of Content

Part 1: Cord Blood Banking Industry - Market Overview & Outlook
I. History of Cord Blood Banking
A. Overview
B. Timeline of Critical Events
II. Likelihood of Needing a Stem Cell Transplant
A. Childhood Probability
B. Full Life-Span Analysis
III. Current, Future, and Projected Conditions Treatable with Cord Blood Transplant
A. Categories of Disease Treatable With Cord Blood Transplant
B. Existing Conditions
C. Therapies in Clinical Trial
1. Human Trials
2. Laboratory Trials
D. Projected Conditions
IV. Cord Blood vs. Bone Marrow and Peripheral Blood, as a Source of Hematopoietic Stem Cells for Transplant
A. Sources of Hematopoietic Stem Cells
B. Global Survey on Use of Hematopoietic Stem Cells in Transplantation (2010 Baseline)
C. Worldwide Statistics on Hematopoietic Stem Cell Transplantation (2013 Data)
V. Cord Blood Banking – Storage Options
A. U.S. Private Banks
B. U.S. Public Banks
1. Free Programs for Families in Medical Need
2. Mail-in Donation (Public) Cord Blood Banks
C. International Summary and Comparison
1. Top 15 Countries for Cord Blood Banking
2. Number of Private Cord Blood Banks by International Region
D. Breakdown of Canadian Cord Blood Banks – Public vs. Private / AABB Accredited vs. Non-  Accredited
E. International Private and Public Cord Blood Banks by Region
1. South America
2. Asia
3. Africa
F. List of International Public Cord Blood Banks (Alphabetical by Country)
G. Worldwide List of AABB Accredited Cord Blood Facilities
Part 2: Expansion and Growth – Trailing 12-Month Analysis & Future Projections
I. Fast-Growth vs. Flat-Growth – Bimodal Distribution
II. Growth Rate
III. Revenue
A. Flat-line Growth Companies (< 3% per year)
B. Substantive Revenue Growth Companies (25% or more per year)
IV. Industry Conditions
A. North America
1. Canada
2. Mexico
3. United States
B. South America
1. Brazil
2. Chile
3. Colombia
C. Asia
1. China
2. India
3. Japan
4. Korea
5. Malaysia
6. Singapore
7. Taiwan
8. Thailand
D. Australia/New Zealand
E. Europe
1. France
2. Germany/Austria
3. Italy
4. Netherlands
5. Poland
6. Russia
7. Spain
8. United Kingdom
V. Trends
A. Rates of Worldwide Cord Blood Storage (Units per Year)
B. Medical Society Opinions of Cord Blood Banking
C. Cord Blood Scientific Publication Rates
D. Cord Blood Research Funding Levels (Grant Analysis)
1. U.S. Grant Funding Analysis
2. Worldwide Grant Funding Analysis
E. Cord Blood Patent Breakdown
F. Rates of Cord Blood Research Product Development
G. Top Countries for Cord Blood Research
H. Cord Blood Conferences & Events
VI. Cord Tissue Storage
A. Overview of Cord Blood Storage vs. Cord Tissue Storage
B. Pricing of Cord Tissue Storage
C. Clinical Trials – Cord Blood vs. Cord Tissue
D. Market Penetration of Cord Tissue Storage
VII. Barriers to Entering the Cord Blood Market
A. Accreditation
1. Types of Accreditation
2. AABB Overview
3. ABB Accredited Cord Blood Banks
4. Current Conditions
B. Security requirements
C. Laboratory and Storage Requirements
D. Cord Blood Banking Legislation
1. United States
2. European Union
VIII. Leveraging Novel Tactics for Substantive Revenue Growth
A.  Strategic Collaborations
1. Regional Hospitals and Birthing Centers
a. Public Banking System
b. Private Banking System
2. Broad-Spectrum Collaborations
B. Careful Selection of Region
C. Establishing Credentials - Indicators of Reputability (Accreditation, Licensure, Transplant Track Records)
D. Merger and Acquisition Potential
E. Multi-National Marketing Framework
F. Parental Referral Programs
G. Effective Communication of Cord Blood Banking Services
H.  Rapid Integration of New Technologies
I. Low-Cost Operating Environment
J. Government Support and Affiliation
K. Utilizing Third-Party Cryogenic Storage Facilities
L. Capital Resources
IX. Comparing to the Competition – Setting Yourself Apart
A. Ten Largest Cord Blood Banks – Pricing and Characteristics Comparison
B. Cost Variation
1. Range of Pricing for U.S. Cord Blood Companies (1-100th percentiles)
a. U.S. Cord Blood Banking Price Range (1-100th percentiles)
b. LOWEST U.S. Pricing
c. HIGHEST U.S. Pricing
d. Average U.S. Cord Blood Costs (25-75thpercentiles)
e. Median Cost of Storage (50thpercentile)
2. Range of Pricing for Canadian Cord Blood Companies (1-100th percentiles)
a. Canadian Fee Price Range (1-100th percentiles)
b. LOWEST Canadian Pricing
c. HIGHEST Canadian Pricing
d. Average Canadian Cord Blood Storage Costs (25-75thpercentiles)
e. Median Canadian Cost of Storage (50thpercentile)
C. Technical Variables
1. Vapor-Phase Storage vs. Liquid-Phase Storage
2. Cryo-bags vs. Cryo-vials
3. Pentastarch vs. Hetastarch
4. Computer Controlled vs. Manual Rate Freezing
5. Whole Sample vs. Volume Reduction
6. High-Control vs. Low-Control Aseptic Processing
D. Corporate Variables
1. Corporate Stability
2. Scientific Expertise
Part 3: Parent Survey - Continuing to Grow by Listening to Expectant Parents
I. Global Expectant Parent Survey (2013)
A. Characteristics of Survey Respondent Population
B. Survey Results - Respondents who Banked Cord Blood Privately
C. Survey Results - Respondents who Banked Cord Blood Publicly
D. Survey Results - Respondents who Did Not Bank Cord Blood
E. Survey Results - All Respondents
II. Summary of Conclusions
Appendix A – Existing Conditions Treatable with Cord Blood Transplant
Appendix B – U.S. List of Cord Blood Banks, by Type of Bank (Private, Hybrid, or Public)
Appendix C – Global List of Cord Blood Banks, 2013
Appendix D – Accreditation Standards by U.S Cord Blood Bank, Public and Private
Appendix E – AABB Accredited Cord Blood Banks Worldwide, 2013
Appendix F – Cord Blood Stem Cell Legislation by U.S. State
Appendix G – Case Study: Virgin Health Bank

No comments:

Post a Comment

Note: only a member of this blog may post a comment.